|
SLC25A13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.514470E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.402000E-02 |
| Normal-vs-Stage2 |
5.621600E-02 |
| Normal-vs-Stage3 |
5.423800E-02 |
| Normal-vs-Stage4 |
1.978370E-03 |
| Stage1-vs-Stage2 |
8.517600E-01 |
| Stage1-vs-Stage3 |
9.907400E-01 |
| Stage1-vs-Stage4 |
1.573150E-01 |
| Stage2-vs-Stage3 |
8.795000E-01 |
| Stage2-vs-Stage4 |
2.277000E-01 |
| Stage3-vs-Stage4 |
1.591760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.239860E-02 |
| Normal-vs-AfricanAmerican |
2.210100E-02 |
| Normal-vs-Asian |
7.352000E-01 |
| Caucasian-vs-AfricanAmerican |
9.798200E-01 |
| Caucasian-vs-Asian |
5.581800E-01 |
| AfricanAmerican-vs-Asian |
5.760600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.021400E-03 |
| Normal-vs-Female |
1.144990E-01 |
| Male-vs-Female |
2.868200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.529830E-02 |
| Normal-vs-Extreme_Weight |
1.497890E-03 |
| Normal-vs-Obese |
3.598900E-03 |
| Normal-vs-Extreme_Obese |
6.464400E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.957000E-01 |
| Normal_Weight-vs-Obese |
7.015200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.601000E-01 |
| Extreme_Weight-vs-Obese |
5.848400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.391590E-01 |
| Obese-vs-Extreme_Obese |
3.510600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.493800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.715900E-02 |
| Normal-vs-Age(61-80Yrs) |
6.157600E-03 |
| Normal-vs-Age(81-100Yrs) |
5.304500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.361400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.198000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.057200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.008000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.618200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.077400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.560300E-02 |
| Normal-VS-Type2 PRCC |
6.318300E-02 |
| Normal-VS-KIRP CIMP |
9.720200E-03 |
| Normal-VS-Unclassified PRCC |
6.671700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.142800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.851430E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.511200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.495200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.863800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.957400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.371730E-02 |
| Normal-vs-N1 |
6.479900E-02 |
| Normal-vs-N2 |
1.072220E-02 |
| N0-vs-N1 |
7.159000E-01 |
| N0-vs-N2 |
1.981390E-01 |
| N1-vs-N2 |
1.302820E-01 |
|
|
